Genprex, INC 8-K filings

NASDAQ
Genprex Inc. has received notice of resignation from executive officer Catherine Vaczy, with discussions ongoing regarding her departure.
NASDAQ
Genprex, Inc. has announced a 1-for-40 reverse stock split, effective February 2, 2024, to increase its stock price and regain compliance with Nasdaq's minimum bid requirement.